111.445 -

-1.965 (-1.73%)
Range 110.950 - 113.960   (2.71%)
Open 113.960
Previous Close 113.410
Bid Price 111.400
Bid Volume 71
Ask Price 111.430
Ask Volume 82
Volume 3,300,960
Value 178,599,049
Remark -
Delayed prices. Updated at 16 May 2026 00:51.
Data powered by
View All Events

About Merck & Co

Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. On July 2, 2014, Santen Pharmaceutical Co., Ltd acquired certain ophthalmology assets from Merck & Co., Inc. On August 5, 2014, Merck & Co Inc (Merck) acquired Idenix Pharmaceuticals Inc (Idenix).

There are 30 followers

Followers
0
Followers
1
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
3
Followers
0
Followers
1
Followers
0
Followers
0
Followers
1
Followers
0
Followers
0
Followers
3
Followers
0
Followers
0
Followers
1
Followers
0
Followers
0
Followers
0
#NewHandSmallWhite
Followers
1
Followers
0
Followers
2
Followers
0
Followers
7
Followers
12